Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GreeceBack to Greece

Clinical trials in Peristeri

6 clinical trials in Peristeri, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.

Peristeri at a glance
6
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Peristeri

Open in trial search

Obesity+1

Recruiting
Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Cardiac failure+1

Recruiting
Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Obesity+1

Recruiting
Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Obesity+2

Not yet recruiting
Investigational
Countries:GreeceGreece
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S

Type 2 diabetes mellitus

Not yet recruiting
Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Obesity

Not recruiting
InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Peristeri

What the registry says about research in the country

01 Peristeri
Cardiovascular Diseases
In Peristeri, researchers are evaluating a weekly injectable agent for patients with HFpEF or HFmrEF who also have obesity, aiming to lower the combined risk of cardiovascular death and heart‑failure hospitalisations. Composite cardiovascular outcome assessment Weekly dosing strategy Integration with standard of care Focus on heart‑failure subtypes Both studies are actively recruiting, involve 25 investigators, and seek to improve treatment options for a growing heart‑failure population.
Nutritional and Metabolic Diseases
Clinical trials in the city are comparing two formulations of injectable cagrilintide and a placebo, as adjuncts to diet and activity counseling, to achieve meaningful weight loss in participants with excess body weight. Weight‑loss non‑inferiority testing Superiority versus placebo evaluation Adjunct lifestyle intervention Targeting overweight and obesity The recruiting studies involve a dedicated team of investigators and aim to expand therapeutic options for metabolic health.
Back to GreeceAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.